Influenza virus vaccine, H5N1 (Sanofi Pasteur)

N/A

Report date: 2026/05/09 20:00:18

Base Information

Drug NameInfluenza virus vaccine, H5N1 (Sanofi Pasteur)
Drug Alias NameInfluenza Virus Vaccine, H5N1
ClassificationVaccines > Biological material > Viral vaccineVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsRespiratory Syncytial Virus InfectionsInfluenza, Human
Global Approved IndicationsInfluenza, Human
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2007/04/17
Country/TerritoryUnited StatesAustralia
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesSanofi
China Registration ClassN/A

Develop Information

Active CompaniesSanofi
Inactive CompaniesNational Institute Of Allergy And Infectious Diseases (Niaid)
Active IndicationsRespiratory Syncytial Virus InfectionsInfluenza, Human
Inactive IndicationsN/A

Other Information

ATC CodeJ07BB01
Related LinksN/A